Markets | Hannibal Courier

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF Regulated InformationChâtillon, France, January 13, 2025

By DBV Technologies S.A. · Via GlobeNewswire · January 13, 2025

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study

Châtillon, France, January 8th, 2025

By DBV Technologies S.A. · Via GlobeNewswire · January 8, 2025

DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

Châtillon, France, December 11th, 2024

By DBV Technologies S.A. · Via GlobeNewswire · December 11, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024

By DBV Technologies S.A. · Via GlobeNewswire · December 2, 2024

DBV Technologies Announces Plan to Implement ADS Ratio Change

Châtillon, France, November 11, 2024

By DBV Technologies S.A. · Via GlobeNewswire · November 11, 2024

DBV Technologies Reports Third Quarter 2024 Financial Results

Châtillon, France, November 6, 2024

By DBV Technologies S.A. · Via GlobeNewswire · November 6, 2024

DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe

Châtillon, France, October 22, 2024

By DBV Technologies S.A. · Via GlobeNewswire · October 22, 2024

DBV Technologies to Participate in Upcoming ACAAI 2024 Congress

Châtillon, France, October 18, 2024

By DBV Technologies S.A. · Via GlobeNewswire · October 18, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024

By DBV Technologies S.A. · Via GlobeNewswire · October 14, 2024

DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial

Châtillon, France, September 23, 2024

By DBV Technologies S.A. · Via GlobeNewswire · September 23, 2024

DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Châtillon, France, September 4, 2024

By DBV Technologies S.A. · Via GlobeNewswire · September 4, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024

By DBV Technologies S.A. · Via GlobeNewswire · August 2, 2024

DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report

Châtillon, France, July 30, 2024

By DBV Technologies S.A. · Via GlobeNewswire · July 30, 2024

DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results

Châtillon, France, July 30, 2024

By DBV Technologies S.A. · Via GlobeNewswire · July 30, 2024

DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024

Châtillon, France, July 29, 2024

By DBV Technologies S.A. · Via GlobeNewswire · July 29, 2024

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF Regulated InformationMontrouge, France, July 8, 2024

By DBV Technologies S.A. · Via GlobeNewswire · July 8, 2024

DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Châtillon, France, June 5, 2024

By DBV Technologies S.A. · Via GlobeNewswire · June 5, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024

By DBV Technologies S.A. · Via GlobeNewswire · June 4, 2024

DBV Technologies Announces Plan to Implement ADS Ratio Change

Châtillon, France, May 31, 2024

By DBV Technologies S.A. · Via GlobeNewswire · May 31, 2024

DBV Technologies to Participate in Upcoming EAACI 2024 Congress

Châtillon, France, May 30, 2024

By DBV Technologies S.A. · Via GlobeNewswire · May 30, 2024

DBV Technologies Announces Plan to Implement ADS Ratio Change

Châtillon, France, May 17, 2024

By DBV Technologies S.A. · Via GlobeNewswire · May 17, 2024

DBV Technologies Announces Results of its 2024 Combined General Meeting

Châtillon, France, May 16, 2024

By DBV Technologies S.A. · Via GlobeNewswire · May 16, 2024

DBV Technologies to Participate in Upcoming Investor Conferences

Montrouge, France, May 9, 2024

By DBV Technologies S.A. · Via GlobeNewswire · May 9, 2024

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update

Montrouge, France, May 7, 2024

By DBV Technologies S.A. · Via GlobeNewswire · May 7, 2024

Combined General Meeting of May 16, 2024

Châtillon, France, April 25, 2024

By DBV Technologies S.A. · Via GlobeNewswire · April 25, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

By DBV Technologies S.A. · Via GlobeNewswire · April 4, 2024

DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document

Montrouge, France, March 8, 2024

By DBV Technologies S.A. · Via GlobeNewswire · March 8, 2024

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

Montrouge, France, March 7, 2024

By DBV Technologies S.A. · Via GlobeNewswire · March 7, 2024

DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024

Montrouge, France, March 4, 2024

By DBV Technologies S.A. · Via GlobeNewswire · March 4, 2024

DBV Technologies to Participate in Upcoming AAAAI 2024 Congress

Montrouge, France, February 20 2024

By DBV Technologies S.A. · Via GlobeNewswire · February 20, 2024

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF Regulated InformationMontrouge, France, January 16, 2024

By DBV Technologies S.A. · Via GlobeNewswire · January 16, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023

By DBV Technologies S.A. · Via GlobeNewswire · December 4, 2023

DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers

Montrouge, France, November 9, 2023

By DBV Technologies S.A. · Via GlobeNewswire · November 9, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023

By DBV Technologies S.A. · Via GlobeNewswire · November 6, 2023

DBV Technologies to Present New Data at ACAAI 2023

Montrouge, France, November 2, 2023

By DBV Technologies S.A. · Via GlobeNewswire · November 2, 2023

DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results

Montrouge, France, October 31, 2023

By DBV Technologies S.A. · Via GlobeNewswire · October 31, 2023

DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update

Montrouge, France, October 27, 2023

By DBV Technologies S.A. · Via GlobeNewswire · October 27, 2023

DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer

Montrouge, France, October 16, 2023

By DBV Technologies S.A. · Via GlobeNewswire · October 16, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

By DBV Technologies S.A. · Via GlobeNewswire · October 5, 2023

DBV Technologies to Participate in Upcoming Investor Conference

Montrouge, France, September 5, 2023

By DBV Technologies S.A. · Via GlobeNewswire · September 5, 2023

DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results

Montrouge, France, July 31, 2023

By DBV Technologies S.A. · Via GlobeNewswire · July 31, 2023

DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update

Montrouge, France, July 25, 2023

By DBV Technologies S.A. · Via GlobeNewswire · July 25, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

By DBV Technologies S.A. · Via GlobeNewswire · July 19, 2023

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF Regulated InformationMontrouge, France, July 10, 2023

By DBV Technologies S.A. · Via GlobeNewswire · July 10, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023

By DBV Technologies S.A. · Via GlobeNewswire · June 16, 2023

DBV Technologies to Participate in Upcoming EAACI Congress 2023

Montrouge, France, June 8, 2023

By DBV Technologies S.A. · Via GlobeNewswire · June 8, 2023

DBV Technologies to Participate in Upcoming Investor Conference

Montrouge, France, June 06, 2023

By DBV Technologies S.A. · Via GlobeNewswire · June 6, 2023

DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers

Montrouge, France, May 10, 2023

By DBV Technologies S.A. · Via GlobeNewswire · May 10, 2023

DBV Technologies to Participate in Upcoming Investor Conference

Montrouge, France, May 9, 2023

By DBV Technologies S.A. · Via GlobeNewswire · May 9, 2023

DBV Technologies Reports First Quarter 2023 Financial Results

Montrouge, France, May 4, 2023

By DBV Technologies S.A. · Via GlobeNewswire · May 4, 2023

DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA

Montrouge, France, April 19, 2023

By DBV Technologies S.A. · Via GlobeNewswire · April 19, 2023

DBV Technologies Announces Results of its 2023 Ordinary and Extraordinary General Meeting

Montrouge, France, April 12, 2023

By DBV Technologies S.A. · Via GlobeNewswire · April 12, 2023

Ordinary and Extraordinary General Meeting of April 12, 2023

Montrouge, France, March 24, 2023

By DBV Technologies S.A. · Via GlobeNewswire · March 24, 2023

DBV Technologies Update

Montrouge, France, March 13, 2023

By DBV Technologies S.A. · Via GlobeNewswire · March 13, 2023

DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old

Montrouge, France, March 7, 2023

By DBV Technologies S.A. · Via GlobeNewswire · March 7, 2023

DBV Technologies announces filing of 2022 Annual Report on Form 10-K and 2022 Universal Registration Document

Montrouge, France, March 2, 2023

By DBV Technologies S.A. · Via GlobeNewswire · March 2, 2023

DBV Technologies Reports Full Year 2022 Financial Results and Business Update

Montrouge, France, March 2, 2023

By DBV Technologies S.A. · Via GlobeNewswire · March 2, 2023

DBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023

Montrouge, France, February 27, 2023

By DBV Technologies S.A. · Via GlobeNewswire · February 27, 2023

DBV Technologies to Participate in Upcoming AAAAI 2023 Congress

Montrouge, France, February 21, 2023

By DBV Technologies S.A. · Via GlobeNewswire · February 21, 2023

DBV Technologies to Participate in Upcoming Investor Conference

Montrouge, France, February 10, 2023

By DBV Technologies S.A. · Via GlobeNewswire · February 10, 2023

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF Regulated InformationMontrouge, France, January 23, 2023

By DBV Technologies S.A. · Via GlobeNewswire · January 23, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022

By DBV Technologies S.A. · Via GlobeNewswire · January 4, 2023

DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial

Montrouge, France, December 23, 2022

By DBV Technologies S.A. · Via GlobeNewswire · December 23, 2022

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022

By DBV Technologies S.A. · Via GlobeNewswire · December 8, 2022

DBV Technologies to Participate in Upcoming Investor Conference

Montrouge, France, November 22, 2022

By DBV Technologies S.A. · Via GlobeNewswire · November 22, 2022

DBV Technologies to Highlight New Clinical Data at ACAAI 2022

Montrouge, France, November 9, 2022

By DBV Technologies S.A. · Via GlobeNewswire · November 9, 2022

DBV Technologies Reports Third Quarter Financial Results and Business Update

Montrouge, France, November 3, 2022

By DBV Technologies S.A. · Via GlobeNewswire · November 3, 2022

DBV Technologies to Report Third Quarter 2022 Financial Results and Provide a Business Update

Montrouge, France, October 31, 2022

By DBV Technologies S.A. · Via GlobeNewswire · October 31, 2022

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2022

Monthly information regarding the total number of voting rights and

By DBV Technologies S.A. · Via GlobeNewswire · October 20, 2022

DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors

Montrouge, France, October 3, 2022

By DBV Technologies S.A. · Via GlobeNewswire · October 3, 2022

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF REGULATED INFORMATIONMontrouge, France, July 27, 2022

By DBV Technologies S.A. · Via GlobeNewswire · July 27, 2022

Articles from DBV Technologies S.A.